Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

RNA splicing machinery offers new drug target

19.05.2015

Blocking the spliceosome delays the progression of lymphoma in mice

A widespread cancer-causing protein called MYC promotes the growth of tumor cells in part by ensuring that RNA transcripts are properly spliced, according to latest work from A*STAR researchers1. Drugs that block parts of the cell’s splicing machinery may provide a new way to halt the proliferation of MYC-driven cancers.


Blocking the spliceosome could inhibit the growth of MYC-driven tumors.

© defun/iStock/Thinkstock

“Cells overexpressing the oncogene MYC will be more sensitive to inhibition of the splicing machinery,” says Ernesto Guccione, from the A*STAR Institute of Molecular and Cell Biology, who led the research. “Targeting the core components of the splicing machinery may be a novel Achilles’ heel to therapeutically target MYC-driven tumors.”

The MYC oncoprotein is a central driver in the majority of human cancers. MYC binds to active regulatory elements in the genome and broadly amplifies gene expression, leading to rampant cell growth. This process, however, is not random or indiscriminate. Guccione, in collaboration with colleagues in Italy, recently showed that MYC preferentially activates distinct subsets of target genes to control cellular states2.

Following up on that observation, Guccione and his colleagues from A*STAR decided to investigate which gene sets are turned on by MYC in mouse models of lymphoma. One gene set that stood out involved components of the spliceosome, the molecular complex that helps prepare messenger RNA (mRNA) transcripts for protein production by removing noncoding segments called introns.

These genes include PRMT5, which codes for a key enzyme that ensures proper maturation of the spliceosomal complex. PRMT5 and others help assemble the proteins that form the spliceosome. Guccione’s team showed that mice with only one functional copy of PRMT5 — instead of the usual two — develop lymphoma more slowly.

PRMT5 depletion led to a range of splicing defects linked to the retarded tumor growth. And drug-like molecules called antisense oligonucleotides (which disrupt proper splicing) also reduced the viability of cancer cells taken from mice with lymphoma. Together, the results suggest that splicing-associated genes like PRMT5 are critical to MYC-driven tumor formation.

Further support for this idea came from human clinical samples. Guccione and colleagues studied samples from people with lymphoma. They found a link between MYC overexpression and the activity of spliceosome-related genes. Notably, high expression of PRMT5 correlated with worse clinical outcomes. In the laboratory, knocking out PRMT5, or another core component of the splicing machinery in human lymphoma cells lines, also reduced cell viability.

“The inhibition of PRMT5 may have potential therapeutic utility in cancer treatment,” explains Cheryl Koh, a postdoctoral fellow in Guccione’s lab and the co-first author of the new study.

The A*STAR-affiliated researchers contributing to this research are from the Institute of Molecular and Cell Biology, the Institute of High Performance Computing and the Bioinformatics Institute.


References
Koh, C. M., Bezzi, M., Low, D. H. P., Ang, W. X., Teo, S. X. et al. MYC regulates the core Pre-mRNA splicing machinery as an essential step in lymphomagenesis. Nature advance online publication, 11 May 2015 (doi: 10.1038/nature14351). | article
Sabò, A., Kress, T. R., Pelizzola, M., de Pretis, S., Gorski, M. M. et al. Selective transcriptional regulation by Myc in cellular growth control and lymphomagenesis. Nature 511, 488–492 (2014). | article

A*STAR Research | ResearchSEA
Further information:
http://www.research.a-star.edu.sg/research/7236
http://www.researchsea.com

More articles from Life Sciences:

nachricht Researchers reveal new details on aged brain, Alzheimer's and dementia
21.11.2017 | Allen Institute

nachricht Nanoparticles help with malaria diagnosis – new rapid test in development
21.11.2017 | Fraunhofer-Institut für Silicatforschung ISC

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Nanoparticles help with malaria diagnosis – new rapid test in development

The WHO reports an estimated 429,000 malaria deaths each year. The disease mostly affects tropical and subtropical regions and in particular the African continent. The Fraunhofer Institute for Silicate Research ISC teamed up with the Fraunhofer Institute for Molecular Biology and Applied Ecology IME and the Institute of Tropical Medicine at the University of Tübingen for a new test method to detect malaria parasites in blood. The idea of the research project “NanoFRET” is to develop a highly sensitive and reliable rapid diagnostic test so that patient treatment can begin as early as possible.

Malaria is caused by parasites transmitted by mosquito bite. The most dangerous form of malaria is malaria tropica. Left untreated, it is fatal in most cases....

Im Focus: A “cosmic snake” reveals the structure of remote galaxies

The formation of stars in distant galaxies is still largely unexplored. For the first time, astron-omers at the University of Geneva have now been able to closely observe a star system six billion light-years away. In doing so, they are confirming earlier simulations made by the University of Zurich. One special effect is made possible by the multiple reflections of images that run through the cosmos like a snake.

Today, astronomers have a pretty accurate idea of how stars were formed in the recent cosmic past. But do these laws also apply to older galaxies? For around a...

Im Focus: Visual intelligence is not the same as IQ

Just because someone is smart and well-motivated doesn't mean he or she can learn the visual skills needed to excel at tasks like matching fingerprints, interpreting medical X-rays, keeping track of aircraft on radar displays or forensic face matching.

That is the implication of a new study which shows for the first time that there is a broad range of differences in people's visual ability and that these...

Im Focus: Novel Nano-CT device creates high-resolution 3D-X-rays of tiny velvet worm legs

Computer Tomography (CT) is a standard procedure in hospitals, but so far, the technology has not been suitable for imaging extremely small objects. In PNAS, a team from the Technical University of Munich (TUM) describes a Nano-CT device that creates three-dimensional x-ray images at resolutions up to 100 nanometers. The first test application: Together with colleagues from the University of Kassel and Helmholtz-Zentrum Geesthacht the researchers analyzed the locomotory system of a velvet worm.

During a CT analysis, the object under investigation is x-rayed and a detector measures the respective amount of radiation absorbed from various angles....

Im Focus: Researchers Develop Data Bus for Quantum Computer

The quantum world is fragile; error correction codes are needed to protect the information stored in a quantum object from the deteriorating effects of noise. Quantum physicists in Innsbruck have developed a protocol to pass quantum information between differently encoded building blocks of a future quantum computer, such as processors and memories. Scientists may use this protocol in the future to build a data bus for quantum computers. The researchers have published their work in the journal Nature Communications.

Future quantum computers will be able to solve problems where conventional computers fail today. We are still far away from any large-scale implementation,...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Ecology Across Borders: International conference brings together 1,500 ecologists

15.11.2017 | Event News

Road into laboratory: Users discuss biaxial fatigue-testing for car and truck wheel

15.11.2017 | Event News

#Berlin5GWeek: The right network for Industry 4.0

30.10.2017 | Event News

 
Latest News

From Hannover around the world and to the Mars: LZH delivers laser for ExoMars 2020

21.11.2017 | Physics and Astronomy

Borophene shines alone as 2-D plasmonic material

21.11.2017 | Materials Sciences

Penn study identifies new malaria parasites in wild bonobos

21.11.2017 | Health and Medicine

VideoLinks
B2B-VideoLinks
More VideoLinks >>>